Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors
Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors Curator: Stephen J. Williams, Ph.D. UPDATED 8/12/2022 Athough not related to IAP Antagonists this update does report 2 deaths from IDILI or idiosynchratic drug induced liver injury from a gene therapy trial using an AAV (adeno associated virus) targeting the disease spinal muscular … Continue reading Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed